UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - plasmids+%2f+vectors
5
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Optimized Lentiviral Vector for Stem Cell Gene Therapy of Hemoglobinopathies
UCLA Case No. 2017-460 Summary UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have developed a novel method to produce short lentiviral vectors with tissue-specific expression, with a primary focus on lentiviral vectors for treating sickle cell disease and other disorders of hemoglobin. Background Sickle...
Published: 1/23/2024
|
Inventor(s):
Donald Kohn
,
Roger Hollis
,
Richard Morgan
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Genetic Disease
,
Life Science Research Tools
,
Plasmids / Vectors
,
Research Methods
,
Therapeutics & Vaccines
,
Viral Delivery Systems
Category(s):
Life Science Research Tools > Plasmids/Vectors
,
Life Science Research Tools
,
Life Science Research Tools > Research Methods
,
Platforms > Drug Delivery
,
Therapeutics
,
Platforms > Drug Delivery > Viral Delivery Systems
,
Therapeutics > Gene Therapy And Editing
2019-880 ZIKA VIRUS-BASED ONCOLYTIC THERAPY FOR BRAIN CANCER
UCLA researchers in the Department of Molecular and Medical Pharmacology have developed a novel zika virus-based oncolytic therapy to treat brain cancer.BACKGROUND: Glioma is a type of brain tumor that accounts for 80% of all primary malignant brain tumors. Standard therapy for high-grade glioma requires a combination of surgical resection, radiation...
Published: 9/12/2023
|
Inventor(s):
Vaithilingaraja Arumugaswami
,
David Nathanson
Keywords(s):
Cns
,
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Immunology
,
Immunotherapy
,
Oncology
,
Oncology Immunotherapy
,
Plasmids / Vectors
,
Therapeutics & Vaccines
,
Viral Delivery Systems
Category(s):
Diagnostic Markers > Immunology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Vaccines
,
Therapeutics > Oncology
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Oncology > Oncology Immunotherapy
2018-749 A METHOD TO DISTINGUISH DIFFERENT RETROVIRAL VECTORS DURING INTEGRATION SITE ANALYSIS
UCLA researchers in the Department of Microbiology, Immunology, and Molecular Genetics have developed a novel gene therapy vector identifying method, capable of screening toxicities of combination therapies.TITLE: A Method to Distinguish Different Retroviral Vectors During Integration Site Analysis BACKGROUND: Many diseases originate from defective...
Published: 7/19/2023
|
Inventor(s):
Irvin S.Y. Chen
,
Gajendra Suryawanshi
,
Sanggu Kim
Keywords(s):
Gene Editing Systems
,
Gene Therapy
,
Life Science Research Tools
,
Plasmids / Vectors
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Life Science Research Tools > Plasmids/Vectors
,
Therapeutics
,
Therapeutics > Gene Therapy And Editing
A Codon-Optimized Lentiviral Vector For Stem Cell Reprogramming (UCLA Case No. 2014-014)
A Codon-Optimized Lentiviral Vector For Stem Cell ReprogrammingSUMMARYUCLA researchers in the Department of Medicine and the Department of Surgery have developed a novel lentiviral vector that expresses a codon-optimized sequence of a T cell receptor (TCR) specific for the cancer-testis antigen NY-ESO-1 as well as a positron emission tomography (PET)...
Published: 2/14/2024
|
Inventor(s):
Antoni Ribas
,
Richard Koya
,
Thinle Chodon
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Immunotherapy
,
iPS/stem cells
,
Life Science Research Tools
,
Plasmids / Vectors
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Life Science Research Tools > Plasmids/Vectors
,
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells
2018-862 GENERATION OF MINIMAL ENHANCER ELEMENTS USING MASSIVELY PARALLEL REPORTER ASSAYS
SummaryUCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have developed a novel method to produce short lentiviral vectors with tissue-specific expression, with a primary focus on lentiviral vectors for treating sickle cell disease and other disorders of hemoglobin.BackgroundSickle cell disease (SCD) is one of the...
Published: 7/19/2023
|
Inventor(s):
Donald Kohn
,
Roger Hollis
,
Richard Morgan
,
Aaron Cooper
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Genetic Disease
,
Life Science Research Tools
,
Plasmids / Vectors
,
Research Methods
,
Therapeutics & Vaccines
,
Viral Delivery Systems
Category(s):
Life Science Research Tools
,
Life Science Research Tools > Plasmids/Vectors
,
Life Science Research Tools > Research Methods
,
Platforms > Drug Delivery
,
Therapeutics
,
Platforms > Drug Delivery > Viral Delivery Systems
,
Therapeutics > Gene Therapy And Editing